A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis

NCT06975748 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Neurotrophic Keratitis

Interventions

DRUG: STSP-0902 ophthalmic solution
DRUG: STSP-0902 ophthalmic solution
DRUG: STSP-0902 Placebo

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd